Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Johnson and Johnson
Express Scripts
Colorcon
Merck

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Sciegen Pharms Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?

SCIEGEN PHARMS INC has thirty-six approved drugs.

There is one tentative approval on SCIEGEN PHARMS INC drugs.

Summary for Sciegen Pharms Inc
US Patents:0
Tradenames:30
Ingredients:29
NDAs:36

Drugs and US Patents for Sciegen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 206384-001 Oct 12, 2016 AB RX No No   See Pricing   See Pricing
Sciegen Pharms Inc QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 209635-003 Nov 29, 2017 AB RX No No   See Pricing   See Pricing
Sciegen Pharms Inc FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 204507-005 Sep 16, 2015 OTC No No   See Pricing   See Pricing
Sciegen Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 204597-003 Mar 16, 2015 AB RX No No   See Pricing   See Pricing
Sciegen Pharms Inc ARIPIPRAZOLE aripiprazole TABLET;ORAL 206383-001 Sep 29, 2016 AB RX No No   See Pricing   See Pricing
Sciegen Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 211282-001 Jan 10, 2019 AB RX No No   See Pricing   See Pricing
Sciegen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 205236-002 May 26, 2017 AA RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Moodys
Express Scripts
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.